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ABSTRACT Immunity to Toxoplasma gondii at early stages of infection in C57BL/6
mice depends on gamma interferon (IFN-) production by NK cells, while at later
stages it is primarily mediated by CD8 T cells. We decided to explore the require-
ment for CD4 T cells during T. gondii infection in Batf3/ mice, which lack CD8
dendritic cells (DCs) that are necessary for cross-presentation of cell-associated anti-
gens to CD8 T cells. We show that in this immunodeficient background on a BALB/c
background, CD4 T cells become important effector cells and are able to protect
Batf3/ mice from infection with the avirulent strain RHΔku80Δrop5. Independently
of the initial NK cell activation, CD4 T cells in wild-type and Batf3/ mice were the
major source of IFN-. Importantly, memory CD4 T cells were sufficient to provide
protective immunity following transfer into Batf3/ mice and secondary challenge
with the virulent RHΔku80 strain. Collectively, these results show that under situa-
tions where CD8 cell responses are impaired, CD4 T cells provide an important alter-
native immune response to T. gondii.
IMPORTANCE Toxoplasma gondii is a widespread parasite of animals that causes
zoonotic infections in humans. Although healthy individuals generally control the in-
fection with only moderate symptoms, it causes serious illness in newborns and
those with compromised immune systems such as HIV-infected AIDS patients. Be-
cause rodents are natural hosts for T. gondii, laboratory mice provide an excellent
model for studying immune responses. Here, we used a combination of an attenu-
ated mutant strain of the parasite that effectively vaccinates mice, with a defect in a
transcriptional factor that impairs a critical subset of dendritic cells, to studying the
immune response to infection. The findings reveal that in BALB/c mice, CD4 memory
T cells play a dominant role in producing IFN- needed to control chronic infection.
Hence, BALB/c mice may provide a more appropriate model for declining immunity
seen in HIV-AIDS patients where loss of CD4 cells is associated with emergence of
opportunistic infections.
KEYWORDS CD4 T cells, HIV-AIDS, chronic infection, dendritic cells, human
immunodeficiency virus, opportunistic infection, toxoplasmosis
Toxoplasma gondii is a promiscuous, obligate intracellular pathogen capable ofinfecting all types of nucleated cells from a wide range of warm-blooded animals
(1). T. gondii replicates inside a protective parasitophorous vacuole, which segregates
the parasite from the cytoplasmic environment and endosome/lysosome system of the
host cell (2). Acute infection is established by rapidly replicating tachyzoites and is
followed by chronic infection in which the parasite differentiates into bradyzoites that
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escape recognition and clearance by host immunity (3). During the acute phase of
infection, the T. gondii protein profilin is recognized by the MyD88-dependent signaling
pathway through recognition by TLR11 and TLR12 (4–6), which are expressed by
CD8 conventional dendritic cells (cDCs) and tissue-resident CD103 cDCs (7), as well
as macrophages and epithelial cells (8). Early recognition of T. gondii or stimulation of
CD8 DCs by soluble tachyzoite antigen (STAg) leads to the production of interleukin
12 (IL-12) (9, 10). Batf3/ mice, which lack CD8 and CD103 cDCs, are therefore
highly susceptible to infection with T. gondii due to inadequate early IL-12 production
(11).
Immunity to T. gondii infection depends on IL-12 for the production of gamma
interferon (IFN-) by NK cells early after infection, and by CD4 and CD8 T cells at later
times (12, 13). Although early defense against T. gondii depends on CD8 cDCs (11),
inflammatory monocytes and macrophages also produce IL-12, reinforcing the signal to
produce IFN- (14, 15). Sustained levels of IFN- are necessary for control of acute and
chronic infection, and the response to this cytokine is necessary on both hematopoietic
cells and tissue cells (16–18). IFN- has numerous effects on cells, including the
induction of immunity-related GTPases (IRGs), which are recruited to the parasito-
phorous vacuole and mediate its disruption (19). Recent evidence also implicates a
second family of interferon-inducible GTPases, called the guanylate binding proteins
(GBPs), which are also important in control of T. gondii infection (20). Host IRG and GBP
proteins are counteracted by virulence factors expressed by type I strains of T. gondii,
including the pseudokinase ROP5 and the active serine/threonine kinase ROP18, which
together prevent recruitment of host effectors and rupture of the parasitophorous
vacuole (21–25).
Adaptive immunity to T. gondii in C57BL/6 mice is primarily mediated by CD8 T cells,
which are critical for controlling acute infection (26–28). In contrast to CD8 depletion,
susceptibility of C57BL/6 mice is only marginally affected by CD4 T cell depletion,
suggesting a dominant role for CD8 T cells in T. gondii immunity in the mouse (26, 27,
29). Furthermore, adoptive transfer of primed CD8 T cells, but not CD4 T cells, protects
C57BL/6 mice against a secondary challenge with a lethal strain (30). CD4 T cells do play
an important role during the priming phase of infection in C3H/HeN mice as their
depletion during vaccination with avirulent strains of T. gondii prevents development
of protective CD8 T cell immunity (31). CD4 T cells are likely important in part for their
ability to produce IL-2 (26, 30, 32, 33). However, CD4 T cells are also an important
alternative source of IFN- in C57BL/6 mice lacking both CD8 T cells and NK cells (34).
Here, we examined the effector function of CD4 T cells during T. gondii infection,
using Batf3/ mice on a BALB/c background, in which NK and CD8 T cells are present
and have normal intrinsic functions but lack CD8 cDCs needed for cross-presentation
to CD8 T cells and for early IL-12 production (11, 35). We show that in the absence of
CD8 cDCs, CD4 T cells become important effector cells in protective immunity to T.
gondii infection in the mouse, highlighting a previously underappreciated role of CD4
T cells in the memory response.
RESULTS
Delayed activation of the innate response in Batf3/ mice. To examine the role
of CD4 T cells in immunity to T. gondii infection, we used Batf3/ mice that lack
CD8 and CD103 cDCs in lymphoid and peripheral tissue, respectively (35). Since
Batf3/ mice are highly susceptible to the type II Prugniaud (Pru) strain of T. gondii
(11), which has intermediate virulence, we tested infection with the highly attenuated
RHΔku80Δrop5 mutant (21, 22), which lacks the key virulence factor ROP5, a polymor-
phic serine threonine (S/T) protein kinase secreted from rhoptries (ROP) of T. gondii. As
previously described (11, 21), infection of wild-type mice with the virulent parental
RHΔku80 strain resulted in a lethal outcome within 8 to 9 days (Fig. 1A and B). Similarly,
Batf3/ mice also succumbed to infection with the RHΔku80 strain, displaying com-
parable uncontrolled growth of the parasite (Fig. 1A and B). Wild-type mice infected
with the attenuated RHΔku80Δrop5 parasite were able to effectively control infection
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(Fig. 1A). In contrast, Batf3/ mice infected with RHΔku80Δrop5 were initially unable
to control growth but subsequently resolved and cleared the infection (Fig. 1A). The
uncontained growth of the attenuated strain RHΔku80Δrop5 in Batf3/ mice at early
time points is consistent with the known role of CD8 cDCs in controlling early T.
gondii replication by driving IL-12 production. Nevertheless, Batf3/ mice uniformly
survived infection by the RHΔku80Δrop5 strain (Fig. 1B), suggesting another mechanism
was able to restore the ability to control infection.
To exclude the chance that pathogen clearance by Batf3/ mice was due to the
previously described infection-mediated reappearance of CD8 cDCs (36), we ana-
FIG 1 Delayed control of avirulent RHΔku80Δrop5 T. gondii infection in Batf3/ mice. (A and B) Wild-type (WT)
and Batf3/ (KO) mice were infected i.p. with 103 RHΔku80 or RHΔku80Δrop5 tachyzoites and monitored over
30 days for parasite growth (A) and survival (B). † indicates number of deaths (in parentheses) (n  5). Results are
representative of at least 2 independent experiments with similar outcomes. The background levels of lumines-
cence in uninfected control mice are 106. (C) Reappearance of CD8 DCs following infection with
RHΔku80Δrop5 was monitored by flow cytometric analysis (FACS). Representative FACS plots of splenocytes from
wild-type (WT) and Batf3/ (KO) mice at the indicated time points pregated on CD11chigh MHC-IIhigh are shown.
For each time point two mice were analyzed per group. The experiment was performed 2 times with similar
outcomes. (D) Wild-type (WT) and Batf3/ (KO) mice were left untreated (no IL-12), treated with recombinant IL-12
(arrows) 2 days before infection (1 IL-12), or 2 days before and 1 day after infection (2 IL-12) with 103
RHΔku80Δrop5 tachyzoites and monitored over 30 days for parasite growth and survival. † indicates number of
deaths and group; n indicates number of mice per group.
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lyzed the kinetics of CD8 DC reappearance following RHΔku80Δrop5 infection
(Fig. 1C). CD8 cDCs were absent in Batf3/ mice before and up to 5 days after
infection, reappearing only by day 9. However, Batf3/ mice began to clear infection
by day 5, before the reappearance of CD8 cDCs (Fig. 1A), suggesting that clearance
was not due to the reappearance of CD8 cDCs, but rather due to some other
mechanism.
Because CD8 DCs mediate early secretion of IL-12 upon infection, we reasoned
that adding exogenous IL-12 might compensate for their absence. Treatment with
recombinant IL-12 was sufficient to reduce the magnitude and delay the initial burst of
parasite growth (Fig. 1D). The parasite burden was controlled in a dose-dependent
manner by exogenous IL-12 administration (Fig. 1D). A single dose of IL-12 was
sufficient in wild-type mice to reduce parasite levels to the limit of detection. In
Batf3/ mice a single dose of IL-12 reduced parasite levels significantly, and a second
treatment 1 day after infection further delayed and limited the growth of
RHΔku80Δrop5 (Fig. 1D).
Early control of T. gondii infection involves IFN- production by NK cells. We
therefore assessed NK cell activation by intracellular IFN- production in wild-type and
Batf3/ mice infected with RHΔku80Δrop5 parasites (Fig. 2A; see also Fig. S1A in the
supplemental material). IFN- production by NK cells in spleen and peritoneal cavity
was detected in wild-type mice 3 days after infection and sustained until day 5 (Fig. 2A
and Fig. S1A). In contrast, NK cell activation in Batf3/ mice was significantly reduced
and delayed relative to wild-type mice (Fig. 2A and Fig. S1A), consistent with impaired
recognition and IL-12 production in the absence of CD8 DCs (11).
Recruitment, differentiation, and maturation of inflammatory monocytes at the site
of infection rely on NK cell activation and are critical for induction of sustained IL-12
production following intraperitoneal (i.p.) infection with T. gondii (37). Despite reduced
activation and IFN- production by NK cells, Batf3/ mice showed greater recruitment
of neutrophils and Ly6Chigh inflammatory monocytes (Fig. 2B) to the site of infection
than did wild-type mice. This difference may depend on the increased parasite burden
in Batf3/ mice compared to wild-type mice, resulting in greater cell death and tissue
damage. Consistent with this hypothesis, Batf3/ mice showed increased production
of the inflammatory cytokines IL-6, CCL2, and tumor necrosis factor alpha (TNF-)
relative to wild-type mice (Fig. S1B). Increased inflammation may also explain the
increased levels of systemic IFN- seen in Batf3/ mice after the parasite burden
peaked (Fig. 1A and Fig. 2C). In summary, Batf3/ mice show increased parasite
burden, inflammation, and systemic IFN- levels after infection by RHΔku80Δrop5
parasites relative to wild-type mice, but rather than succumbing to infection, they are
able to clear the pathogen during the first weeks of infection.
Clearance of the parasite occurs through CD4-specific IFN- production. The
timing of parasite clearance around day 5, which coincided with delayed IFN- re-
sponse, suggested that T cell-mediated immunity was involved in control of
RHΔku80Δrop5 parasites. We therefore treated wild-type and Batf3/ mice with a
combination of neutralizing anti-CD4 and anti-CD8 antibodies or isotype control anti-
body (Fig. 3A). Batf3/ mice succumbed to infection with RHΔku80Δrop5 parasites
upon specific depletion of T cells, confirming that clearance relied on an efficient T cell
response (Fig. 3A and B). In contrast, depletion of CD4 and CD8 T cells had no impact
on RHΔku80Δrop5 parasite burdens in wild-type mice. These results indicate that
infection with the highly attenuated RHΔku80Δrop5 strain can be eliminated indepen-
dently of T cell function in wild-type mice, presumably due to early IFN- produced by
NK cells (Fig. 2A).
Either CD8 or CD4 T cells or the combination of the two could be responsible for the
observed clearance of RHΔku80Δrop5 parasites in Batf3/ mice. To test these alter-
native models, we depleted CD4 or CD8 T cells in Batf3/ mice and evaluated
infection with RHΔku80Δrop5 parasites. Depletion of CD4 T cells caused lethality in the
majority of mice, which succumbed by day 10 after infection (Fig. 3C and D). In contrast,
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single depletion of CD8 T cells had no effect on RHΔku80Δrop5 parasite burden in
Batf3/ mice (Fig. 3C) and only a minor effect on overall survival of the mice (Fig. 3D).
Pathogen clearance was dependent on IFN-, since administration of neutralizing
antibody at the peak of infection on day 4 was uniformly lethal (Fig. 3C and D). Analysis
of IFN--secreting CD4 and CD8 T cells in the spleen and peritoneum revealed a
different kinetic response between wild-type and Batf3/ mice (Fig. 3E and Fig. S2A).
In wild-type mice, CD4 T cells began production 3 days after infection and peaked at
day 7, when parasite burden had been reduced to the limit of detection. In Batf3/
mice, CD4 T cell activation was delayed until day 7 and peaked at day 10, after which
parasites were eliminated (Fig. 3E and Fig. S2A). CD8 T cell responses followed a similar
kinetic as CD4 T cell responses (Fig. 3E and Fig. S2A). Despite the absence of CD8
cDCs in Batf3/ mice, CD8 T cells produced significant amounts of IFN- at later time
points and reached levels similar to wild-type mice, suggesting that the CD8 T cell
response in Batf3/ mice was restored at later time points.
FIG 2 Contribution of innate immune subsets in the control of avirulent RHΔku80Δrop5 T. gondii infection. (A) Wild-type (WT) and
Batf3/ (KO) mice were infected (i.p.) with 103 RHΔku80Δrop5 tachyzoites. The percentage of IFN--positive NK cells in the spleen (left
panel) and peritoneal cavity (right panel) of wild-type and Batf3/ (KO) mice was analyzed by FACS over the course of infection. (n  2
per time point). The experiment was performed 2 times with similar outcomes. Data are represented as means  SD. (B) Wild-type (WT)
and Batf3/ (KO) mice were infected (i.p.) with 103 RHΔku80Δrop5 tachyzoites. Indicated are the numbers of neutrophils (left panel) and
inflammatory monocytes (right panel) recruited/present in the peritoneal cavity of wild-type and Batf3/ mice. Counts were calculated
based on the absolute numbers of cells collected from the peritoneal cavity and the percentage of cells obtained by FACS analysis (n  2
per time point). The experiment was performed 2 times with similar outcomes. Data are represented as means  SD. (C) Wild-type (WT)
and Batf3/ (KO) mice were infected i.p. with 103 RHΔku80Δrop5 tachyzoites. Systemic IFN- levels were measured in the serum of
infected mice (n  2 per time point). The experiment was performed 2 times with similar outcomes. Data are represented as means 
SD. The statistical significance is indicated as follows: *, P  0.05; **, P  0.01; ***, P  0.001.
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CD4 T cells are sufficient to protect Batf3/ mice in an adoptive transfer
model. To further confirm that CD4 T cells were the major effectors of parasite
clearance, we performed adoptive transfer experiments. Batf3/ donor mice were
infected with RHΔku80Δrop5 parasites. After clearance of the parasites and contraction
of the T cell population 30 days postinfection, CD4 and CD8 T cells were collected from
spleens and transferred into nonirradiated Batf3/ recipients. Batf3/ naive recipient
FIG 3 CD4 T cell-mediated clearance of infection via IFN- production. (A and B) Batf3/ (KO) mice were injected with isotype or a combination of anti-CD4
and anti-CD8 depleting antibodies 1 day before and 7 days after infection with 103 RHΔku80Δrop5 tachyzoites and monitored over 30 days for parasite growth
(A) and survival (B). † indicates number of deaths (n  5). (C and D) Batf3/ (KO) mice were injected with isotype or depleting anti-CD4 or anti-CD8 or blocking
anti-IFN- antibodies. Anti-CD4 and anti-CD8 antibodies were given 1 day before and 7 days after infection; anti-IFN- was given 4 days after infection with
103 RHΔku80Δrop5 tachyzoites. Mice were monitored over 30 days for parasite growth (C) and survival (D). † indicates number of deaths (n  5). (E) Wild-type
(WT) and Batf3/ (KO) mice were infected (i.p.) with 103 RHΔku80Δrop5 tachyzoites. Percentages of IFN--positive CD4 cells in the spleen (left panel) and
peritoneal cavity (right panel) of wild-type and Batf3/ mice were monitored over the course of infection. The experiment was performed 2 times with similar
outcomes. Data are represented as means  SD. The statistical significance is indicated as follows: *, P  0.05; **, P  0.01; ***, P  0.001.
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mice received either CD4 or CD8 T cells from Batf3/ naive or infected mice 1 day
before infection with RHΔku80Δrop5 parasites and were monitored for 30 days. As
expected, transfer of naive CD4 or CD8 T cells did not affect the parasite burden
(Fig. 4A). Similarly, primed CD8 T cell transfer was not protective, with mice displaying
a comparable parasite load as following transfer with naive T cells. However, primed
CD4 T cells were sufficient to reduce the growth of RHΔku80Δrop5 parasites in Batf3/
mice, showing a similar parasite burden as RHΔku80Δrop5-infected wild-type mice
(Fig. 1A and Fig. 4A). These studies demonstrate the effector potential of primed CD4
T cells.
CD4 memory T cells protect Batf3/ and WT mice in a vaccination model.
Infection with RHΔku80Δrop5 was previously shown to protect mice from secondary
challenge with the parental RHΔku80 strain, which is normally uniformly lethal (21).
Previous experiments with type I strains of T. gondii showed that the establishment of
protective immunity by vaccination with avirulent strains mostly depends on CD8 T
cells (30). Given the importance of CD4 T cell responses in Batf3/ mice in limiting
RHΔku80Δrop5 parasite burdens (Fig. 3E, Fig. 4A, and Fig. S2A), we decided to examine
the contribution of CD8 and CD4 T cells in protective immunity. Wild-type and Batf3/
mice were infected with avirulent RHΔku80Δrop5 parasites, and after 30 days they were
challenged with virulent RHΔku80 parasites and monitored for 30 days. Wild-type as
FIG 4 Primed CD4 T cells are sufficient to control parasite burden in Batf3/ mice. (A) Primed T cells
were harvested from the spleen of Batf3/ (KO) mice 21 days postinfection. Naïve or primed T cells (as
indicated) were transferred into Batf3/ (KO) mice 2 days before infection with 103 RHΔku80Δrop5
tachyzoites. Mice were monitored over 30 days for parasite growth and survival (n  4). (B) Wild-type
(WT) and Batf3/ (KO) mice were vaccinated with 103 RHΔku80Δrop5 tachyzoites or medium alone as
indicated and challenged 30 days later with 103 RHΔku80 tachyzoites. Survival after challenge was
monitored (n  5). (C) Wild-type (WT) and Batf3/ (KO) mice were untreated or vaccinated with 103
RHΔku80Δrop5 tachyzoites. Thirty days later, vaccinated wild-type and Batf3/ (KO) mice were injected
with isotype control or anti-CD4 depleting antibody, before challenge with 103 RHΔku80 tachyzoites.
Survival after challenge was monitored (n  10 except for WT and KO untreated [n  9]; results combined
from 2 independent experiments).
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well as Batf3/ mice survived the secondary challenge with wild-type parasites
(Fig. 4B), suggesting that adaptive responses to primary infection were sufficient to
induce long-term memory response. Since CD4 T cells were previously shown to be
required during the priming phase for the establishment of an effective CD8 T cell
response but not as effector cells, we performed CD4 depletion before the challenge
phase with the virulent strain. Consistent with the results obtained for Batf3/
infection with the avirulent strain RHΔku80Δrop5 (Fig. 4A), depletion of CD4 T cells
before challenge with RHΔku80 significantly affected survival of Batf3/ mice (Fig. 4C).
Increased susceptibility was also observed in wild-type mice (Fig. 4C), suggesting that
CD4 T cells contribute not only in providing help to CD8 T cells during the priming
phase but also as effector cells in controlling and clearing the parasite.
DISCUSSION
Previous studies have shown that Batf3/ mice, which lack CD8 cDCs, are
unable to control infection following challenge with strains of T. gondii that have
intermediate virulence due to defective recognition of the parasite at early time points
after infection, resulting in reduced IL-12 production and hence defective NK cell
activation (11, 36) However, in Batf3/ mice, CD8 T cell priming can still occur through
presentation of soluble antigens (38), as well as direct presentation, suggesting that
adaptive immunity may only be partially affected. Here, we examined the ability of
Batf3/ mice to control infection with a highly attenuated parasite mutant to distin-
guish between a requirement during innate (IL-12 production) and that during adap-
tive (cross-presentation to CD8 T cells) immunity. In this context, we show that CD4 T
cell production of IFN- becomes critical to control of infection. Selective depletion or
adoptive transfer of T cell subsets revealed that CD4 cells contribute more to produc-
tion of IFN- and to protective responses than do CD8 T cells. Collectively, our results
highlight a previously underappreciated role for CD4 T cells in mediating protective
immunity, a finding that may have consequences for immunocompromised patients
infected with T. gondii.
In wild-type mice, the initial recognition of T. gondii by TLR11 and TLR12 expressed
by CD8 cDCs triggers early IL-12 production and NK cell-mediated secretion of IFN-
leading to control parasite infection (4, 6, 39). In Batf3/ mice, this early IL-12
production is absent (11) with an increased parasite burden leading to greater proin-
flammatory cell recruitment. Despite the increased recruitment of inflammatory mono-
cytes to the peritoneal cavity of Batf3/ mice, this did not lead to parasite control. This
failure to control the parasite numbers may be a consequence of low levels of IFN-
produced by resident NK cells and delayed levels of production by CD4 T cells in
Batf3/ mice. As such, even though inflammatory monocytes are recruited to the site
of infection, their lower capacity for IL-12 production and consequent lower levels of
IFN- at these early time points impair the development of antimicrobial functions.
Furthermore, our findings indicate that control of attenuated strains of T. gondii in
Batf3/ mice is dependent on the function of CD4 T cells, as shown by depletion
studies, rather than simply a reappearance of CD8 cDCs, which are eventually rescued
though production of IL-12 (36). Previous studies have shown that this restoration of
CD8 cDCs is dependent on compensatory function of other Batf transcription factors
that interact with Irf4 and Irf8 to activate gene expression (36). However, these prior
studies did not examine the role of CD4 T cells in control of chronic infection, as they
were focused exclusively on the innate phase of immunity. Our current studies reveal
that despite this return of CD8 DCs, CD4 T cells remain the dominant subset contrib-
uting to IFN- levels needed to control toxoplasmosis.
Although protection against toxoplasmosis in the immunocompetent C57BL/c mice
is largely dependent on CD8 T cells, in the absence of NK cells and CD8 T cells, CD4 T
cells become an essential source for IFN- (34). Similarly, because Batf3/ mice have
impaired cross-presentation of cell-associated but not soluble antigens to CD8 T cells
(38), we reasoned that adaptive immunity in these mice might be more dependent on
CD4 T cell function. Consistent with this prediction, we show that in Batf3/ mice on
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a BALB/c background, CD4 T cells contribute to control of parasite infection. Selective
depletion of CD4, but not CD8, T cells led to increased mortality in chronically infected
Batf3/ and wild-type BALB/c mice. The greater role for CD4 T cells in this model may
be due to their higher production of IFN-. The finding that CD4 cells play a more
important role in the present study differs from previous studies using vaccination with
a strain of intermediate virulence (type II ME49 strain) where CD8 cells were predom-
inant (26, 30, 32). These differences may result from unique mechanisms of activation
caused by the attenuated RHΔku80Δrop5 strain or reflect differences in the use of
BALB/c mice here from previous studies that focused on C57BL/6 mice. Regardless,
neutralization of IFN- was detrimental and resulted in the death of all RHΔku80Δrop5-
vaccinated animals, indicating that the likely mechanism by which CD4 T cells induce
parasite clearance is through secretion of IFN-. This observation highlights the critical
role of IFN--induced pathways in promoting lysis of the parasitophorous vacuole, a
process that occurs through recruitment of IRGs (19) and GBPs (40–42), thereby limiting
and controlling the infection. Collectively, these studies highlight the remarkable
flexibility of the immune system, which provides layers of redundancy needed to
respond to pathogens under a variety of circumstances.
CD4 T cells normally play a minor role in control of T. gondii infection in immune
sufficient hosts, where infections are usually well contained and largely asymptomatic.
Consistent with this, in wild-type mice with the avirulent RHΔku80Δrop5 strain, deple-
tion of CD4 T cells did not affect the parasite burden or survival. Innate protection
mediated by activated NK cells, and production of IFN-, is apparently sufficient for
clearance of this highly attenuated strain. However, in both Batf3/ and wild-type
mice, CD4 memory T cells contributed to the protection of mice after challenge with
lethal infection. This unanticipated result indicates that CD4 T cells contribute to
immunity against T. gondii infection in chronically infected animals, as shown previ-
ously using C3H/HeN mice (31). This finding is also highly relevant to situations where
the parasite burden may increase due to reactivation. In particular, T. gondii reactivation
during immune suppression or in AIDS patients leads to severe and widespread tissue
damage with a potential lethal outcome if left untreated (43). During the progression
to AIDS, T. gondii reactivation results in encephalitis, and the progressive loss of CD4 T
cells is associated with the progression of toxoplasmosis, supporting the relevance of
CD4 T cell-mediated immunity. Hence, findings from BALB/c mice may provide an
improved model to study the pathology of opportunistic infections in immunocom-
promised patients such as those with HIV-AIDS.
MATERIALS AND METHODS
Mice. Wild-type BALB/c mice were originally purchased from Taconic and then bred in-house for
experimental use. Batf3/ mice were previously generated in our laboratory on a 129S6/SvEv back-
ground (35) and subsequently backcrossed for 10 generations onto BALB/c backgrounds. Mice were age
and sex matched for each experiment and were between 8 and 12 weeks old. All mice were maintained
under specific-pathogen-free conditions according to institutional guidelines and with protocols ap-
proved by the Animal Studies Committee of Washington University.
Parasites and infections. Luciferase-expressing parasite strains for type I virulent RH (RHku80) and
an avirulent RH mutant (RHku80rop5) were grown in culture in human foreskin fibroblasts as
previously described (21). For infections, parasites were harvested and counted, and 1,000 tachyzoites
were injected i.p. into mice. Parasite burdens were measured by bioluminescence using luciferase-
expressing parasites, as previously described (21). For survival experiments, mice were monitored daily
over 30 days.
Luciferase imaging. Mice were injected i.p. with D-luciferin (Biosynth AG) at 150 mg/kg of body
weight, anesthetized with 2% isoflurane for 5 min, and imaged with a Xenogen IVIS 200 imager, and
images were processed using Xenogen Living Image software (Caliper Life Sciences).
Cell preparation. Spleens were digested in 5 ml complete Iscove’s modified Dulbecco’s medium
(IMDM) with 250 g/ml collagenase B (Roche) and 30 U/ml DNase I (Sigma-Aldrich) for 30 min at 37°C
with agitation using stir bars. Red blood cells were lysed by incubation in ACK (ammonium-chloride-
potassium) lysis buffer. Cells were filtered through 80-m strainers and counted on an analyzer (Vi-CELL;
Beckman Coulter). Cells (1  106 to 5  106) were stained for flow cytometric analysis. For analysis of
peritoneal cells, a peritoneal lavage was performed with 10 ml Dulbecco’s phosphate-buffered saline
(DPBS). Harvested cells were lysed in ACK buffer, filtered, counted, and stained for flow cytometry.
Flow cytometry and staining. Cells were incubated for 5 min at 4°C with Fc Block (clone 2.4G2; BD)
in FACS buffer (PBS, 0.5% bovine serum albumin [BSA], 2 mM EDTA). Dead cells were excluded using the
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LIVE/DEAD Aqua fixable dead-cell stain kit (Invitrogen). Surface staining was done for 20 min at 4°C in
FACS buffer. Absolute cell numbers were calculated using the total cell count multiplied successively by
the percentages for the appropriate gates obtained through flow cytometry. Cells were analyzed on a BD
FACS Canto II flow cytometer, and data were analyzed using FlowJo software (Tree Star, Inc.). Immune
subsets were identified as previously described (11). Cell types were defined by the following markers:
neutrophils, Ly6hi, F4/80, Ly6Clo, CD11b; inflammatory macrophages/monocytes, Ly6G, Ly6Chi,
CD115hi, CD11c; resident macrophages, Ly6G, F4/80, CD115hi, CD11c; CD8 dendritic cells, CD11c,
MHC-IIhi, DEC205, CD103, CD8a, CD11b, Sirp; CD4 dendritic cells, CD11c, MHC-IIhi, CD11b,
Sirp.
Intracellular cytokine staining. For intracellular cytokine staining, cells were first surface stained
and then fixed in 2% paraformaldehyde for 15 min at room temperature. Cells were then resuspended
in permeabilization buffer (PBS  0.1% BSA  0.5% saponin) and stained with anti-IFN- for 30 min at
4°C.
Cytokine measurement. Serum cytokine levels were measured using the BD CBA mouse inflam-
mation kit (BD Biosciences). Detection was performed using a FACS Canto II flow cytometer (BD
Biosciences), and results were analyzed using FCAP Array (Soft Flow, Inc.).
Administration of IL-12. Recombinant murine IL-12 (Peprotech) was resuspended in pyrogen-free
saline at a concentration of 2.5 g/ml, aliquoted, and frozen at 80°C. Mice were injected i.p. with 0.5 g
of IL-12 as indicated.
IFN- and T cell depletion. Mice were injected i.p. with 250 g of anti-CD4 (clone GK1.5) and/or CD8
(clone H35) 2 days before infection, with a second dose given at day 5 postinfection. Depletion was
monitored on peripheral blood. Mice were injected i.p. with 250 g of IFN--blocking antibody H22, or
control antibody PIP, as previously described (17).
T cell adoptive transfer. CD4 (clone L3T4) and CD8 (clone Ly2) positive T cells were obtained by
positive selection using microbead-based magnetically activated cell sorting (MACS) purification (Milte-
nyi Biotec). Purity was confirmed by fluorescence-activated cell sorting (FACS) analysis above 93%, and
cells were injected intravenously 2 days before infection.
Statistics. For analyses of survival data, the log rank test was used. For analyses of all other data, a
two-way analysis of variance (ANOVA) was used with posttest correction using the Bonferroni method
(Prism; GraphPad Software, Inc.). All data are represented as means  SD. The statistical significance is
indicated as follows: *, P 	 0.05; **, P 	 0.01; ***, P 	 0.001.
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